SEER.US Seer Inc

Healthcare Life Sciences Tools & Services USA Stocks
1.46 USD
Close of Nov 18, 2026
1.42 2.38
Market cap
USD 81.5M
P/E
-
P/B
0.39x
ROE
-29.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SEER.US undervalued?

Graham number

The Graham number of Seer Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Seer Inc fundamental analysis

No fundamental analysis for Seer Inc yet.

Seer Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Seer Inc

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorpo…

Full company profile